StockData
Armata Pharmaceuticals, Inc. logo

Armata Pharmaceuticals, Inc. (ARMP) stock

ARMPNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 4/30
$2.66−0.33 (-11.04%)

Close on Nov 17, 2026Market cap $98.90MP/E –Yield –

Armata Pharmaceuticals price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Armata Pharmaceuticals's price to sales ratio was 204.9× on Jul 31, 2015.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2015Jul 31, 2015204.9×–

More Armata Pharmaceuticals figures

See a number that looks wrong?